Phenytoin is administered in various dosages depending on the patient's age, specific medical condition, and individual response.
How is Phenytoin Dosing Determined?
Dosage for phenytoin is typically individualized. For adults, the usual maintenance dose ranges from 300 mg to 400 mg per day, divided into one to four doses. However, initial loading doses may be higher to achieve therapeutic levels more quickly. Pediatric dosing is usually calculated based on body weight, often ranging from 5 mg/kg/day to 10 mg/kg/day, also divided into multiple doses [1].
What Factors Influence Phenytoin Dosing Adjustments?
Several factors can affect phenytoin levels and necessitate dosage adjustments. These include liver function, kidney function, other medications the patient is taking, and the presence of certain medical conditions like pregnancy [2]. Drug interactions are particularly important; for example, medications that induce or inhibit liver enzymes can significantly alter phenytoin metabolism [3].
How is Phenytoin Effectiveness Monitored?
Monitoring serum phenytoin levels is crucial to ensure efficacy and avoid toxicity. Therapeutic levels are generally considered to be between 10 and 20 mcg/mL. Levels above this range can lead to phenytoin toxicity, characterized by symptoms such as nystagmus, ataxia, confusion, and slurred speech. Conversely, levels below this range may indicate insufficient therapeutic effect [1].
When Does Phenytoin Patent Protection End?
Information regarding the patent expiry for phenytoin is not readily available on DrugPatentWatch.com at this time. Generally, as a long-established medication, its original patents have likely expired, paving the way for generic versions.